company background image
SEQUA logo

Sequana Medical ENXTBR:SEQUA Stock Report

Last Price

€1.56

Market Cap

€44.1m

7D

6.8%

1Y

-68.9%

Updated

28 Mar, 2024

Data

Company Financials +

SEQUA Stock Overview

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure.

SEQUA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Sequana Medical NV Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sequana Medical
Historical stock prices
Current Share Price€1.56
52 Week High€5.18
52 Week Low€1.36
Beta0.88
1 Month Change-39.77%
3 Month Change-61.00%
1 Year Change-68.92%
3 Year Change-82.43%
5 Year Change-76.72%
Change since IPO-81.47%

Recent News & Updates

Recent updates

Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Mar 19
Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Jan 26
Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Dec 03
Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Shareholder Returns

SEQUABE Medical EquipmentBE Market
7D6.8%1.0%3.5%
1Y-68.9%14.7%-2.4%

Return vs Industry: SEQUA underperformed the Belgian Medical Equipment industry which returned 14.7% over the past year.

Return vs Market: SEQUA underperformed the Belgian Market which returned -2.4% over the past year.

Price Volatility

Is SEQUA's price volatile compared to industry and market?
SEQUA volatility
SEQUA Average Weekly Movement16.2%
Medical Equipment Industry Average Movement5.5%
Market Average Movement3.6%
10% most volatile stocks in BE Market7.0%
10% least volatile stocks in BE Market2.5%

Stable Share Price: SEQUA's share price has been volatile over the past 3 months.

Volatility Over Time: SEQUA's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Belgian stocks.

About the Company

FoundedEmployeesCEOWebsite
200670Ian Crosbiehttps://www.sequanamedical.com

Sequana Medical NV develops and commercializes treatment of fluid overload in liver disease, cancer, and heart failure. The company’s products include alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; Direct Sodium Removal (DSR) for the treatment of persistent congestion due to heart failure; and alfapump DSR, a fully implanted system for direct sodium removal therapy in patients with fluid overload due to heart failure. It operates in Belgium, Germany, France, Switzerland, and internationally.

Sequana Medical NV Fundamentals Summary

How do Sequana Medical's earnings and revenue compare to its market cap?
SEQUA fundamental statistics
Market cap€44.06m
Earnings (TTM)-€32.37m
Revenue (TTM)€842.41k

52.3x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SEQUA income statement (TTM)
Revenue€842.41k
Cost of Revenue€189.89k
Gross Profit€652.53k
Other Expenses€33.02m
Earnings-€32.37m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Apr 23, 2024

Earnings per share (EPS)-1.15
Gross Margin77.46%
Net Profit Margin-3,842.71%
Debt/Equity Ratio-465.1%

How did SEQUA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.